Find your next paid study

Stephen FreedlandNCT05832086

~$75 – $3,000

Actual pay is set by the research site.

HypertensionCardiovascular DiseasesCardiovascular Risk Factors+2 more

Sleep and Circadian Mechanisms in Hypertension

This study is a mechanistic clinical trial designed to investigate the effects of the circadian system and sleep on non-dipping blood pressure (BP) in people w…

Oregon Health and Science UniversityNCT05184933

Actual pay is set by the research site.

Older Men's Decision Making About Active Surveillance for Prostate Cancer - Aim 3: Decision Aid Efficacy Testing

This protocol describes pilot testing of an educational shared decision-making intervention to help men with localized prostate cancer make decisions with thei…

Prostate Cancer

M.D. Anderson Cancer CenterNCT06785441

Actual pay is set by the research site.

Cognitive ImpairmentSleep Quality

The Benefits of Nicotinamide Riboside Upon Cognition and Sleep in Older Veterans

Poor sleep quality and short sleep duration may be a mechanistic component of cognitive impairment in older adults, associated with a decline in brain-derived …

State University of New York at BuffaloNCT05500170

Actual pay is set by the research site.

Gambling DisorderGambling Problem

A Randomized Clinical Trial of Contingency Management for Gambling Disorder: Enhancing Treatment Retention and Outcomes

The aim of this study is to conduct a trial to investigate the effectiveness of adding contingency management treatment (CM) to standard care cognitive behavio…

East Tennessee State UniversityNCT07016100

Actual pay is set by the research site.

FibromyalgiaLupus Erythematosus, SystemicChronic Pelvic Pain+1 more

Brief Pain Exposure Therapy (BPET) For Nociplastic Pain

This study is intended to test whether a brief Zoom-based behavioral treatment can help adults with fibromyalgia (FM), Lupus, chronic pelvic pain, and chronic …

University of MichiganNCT06208514

Actual pay is set by the research site.

Phase 2

Pembrolizumab for Advanced Cutaneous Sarcomas Not Including Angiosarcoma

This is a single arm, open-label phase II study to assess the efficacy of single agent pembrolizumab for the treatment of advanced cutaneous sarcomas. Adult pa…

Cutaneous Sarcoma

H. Lee Moffitt Cancer Center and Research InstituteNCT07007273

~$75 – $2,000

Actual pay is set by the research site.

Phase 1

A Phase 1b Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of Intrathecally Administered ION356 in Patients With Pelizaeus Merzbacher Disease

The primary purpose of this study is to evaluate the safety and tolerability of ION356.

Pelizaeus-Merzbacher Disease

Ionis Pharmaceuticals, Inc.NCT06150716

~$150 – $4,200

Actual pay is set by the research site.

Vaginal Metabolome Healthy Volunteers Study

The purpose of this study is to examine the role of the bacterial environments and metabolites in the early detection and prediction of ovarian cancer developm…

Ovarian CancerGenetic Predisposition to Disease

Abramson Cancer Center at Penn MedicineNCT06962059

Actual pay is set by the research site.

DementiaAlzheimer DiseaseCaregiver Stress

A Randomized Controlled Trial of a Care Partner-Centered Structured Retrieval Practice Intervention for Dementia Caregiver Education and Well-Being

Caring for a person living with dementia can be stressful, and many family caregivers report limited access to effective educational resources for managing dem…

Virginia Wesleyan UniversityNCT07413406

Actual pay is set by the research site.

Phase 1

A Phase 1/2, Open-Label, Multicenter, FIH Study to Evaluate the Safety, Tolerability, Pharmacokinetics/Pharmacodynamics, and Preliminary Efficacy of ISM6331 in Participants With Advanced/Metastatic Mesothelioma or Other Advanced Solid Tumors

This is a Phase 1/2, open-label, multicenter, FIH study to evaluate the safety, tolerability, recommended Phase 2 dose (RP2D), PK/PD, and preliminary anti-tumo…

Malignant MesotheliomaMetastatic Malignant Solid TumorAdvanced Solid Tumor

InSilico Medicine Hong Kong LimitedNCT06566079

~$150 – $4,200

Actual pay is set by the research site.

Phase 1

A Phase Ib, Open Label Study to Evaluate Safety of Axicabtagene Ciloleucel Reinfusion (Axi-Cel-2) in Patients With Relapsed and/or Refractory Second Line High-Risk Non-Hodgkin Lymphoma After Standard of Care Axi-Cel

This is a phase Ib study to establish safety of Axi-Cel-2 in patients with Large B Cell Lymphoma (LBCL) who are at high risk of relapse.

Non-Hodgkin LymphomaLarge B-cell Lymphoma